Skip to main content

Table 2 Impact of baseline covariates on (1) odds of receiving ARB relative to ACEI and (2) follow up Hgb levels (Factors Used in Doubly Robust Analysis)

From: Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels

  Effect on follow up Hgb in g/dL (95% CI)
   Overall ACEI ARB
Baseline covariate OR (95% CI) for receiving ARB relative to ACEI (N = 701) (N = 519) (N = 182)
AGE 1.00 (0.98, 1.02) 0.00 (−0.01, 0.01) −0.00 (−0.01, 0.01) −0.00 (−0.02, 0.02)
Sex (female) 1.40 (0.96, 2.05) −0.32 (−0.47, -0.17) −0.29 (−0.47, -0.11) −0.47 (−0.75, -0.20)
Diabetes mellitus 1.16 (0.81, 1.67) 0.01 (−0.14, 0.15) −0.03 (−0.20, 0.15) 0.15 (−0.13, 0.42)
Hypertension 2.82 (1.12, 7.13) 0.29 (−0.01, 0.58) 0.21 (−0.12, 0.54) 0.49 (−0.24, 1.22)
CHF 1.90 (0.98, 3.68) 0.42 (0.14, 0.70) 0.56 (0.20, 0.91) 0.13 (−0.33, 0.58)
Hgb (pre) 0.89 (0.78, 1.02) 0.59 ( 0.53, 0.64) 0.60 (0.54, 0.66) 0.57 (0.48, 0.66)
CKD 1.19 (0.75, 1.89) −0.15 (−0.34, 0.04) −0.09 (−0.31, 0.14) −0.31 (−0.64, 0.03)
Year of initiation of treatment 0.86 (0.74, 1.01) −0.05 (−0.11, 0.01) −0.05 (−0.13, 0.02) −0.03 (−0.15, 0.09)